Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436(7047):117-22. doi:10.1038/nature03664
Sanjana NE, Cong L, Zhou Y, Cunniff MM, Feng G, Zhang F. A transcription activator-like effector toolbox for genome engineering. Nat Protoc. 2012;7(1):171-92. doi:10.1038/nprot.2011.431
Gevers D, Knight R, Petrosino JF, et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol. 2012;10(8):e1001377. doi:10.1371/journal.pbio.1001377
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499(7456):43-9. doi:10.1038/nature12222
Peters A, Yosef N. Understanding Th17 cells through systematic genomic analyses. Curr Opin Immunol. 2014;28:42-8. doi:10.1016/j.coi.2014.01.017
Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 2014;513(7518):382-7. doi:10.1038/nature13438
Meissner A. (Epi)genomics approaches and their applications. Methods. 2015;72:1-2. doi:10.1016/j.ymeth.2014.12.011
Logue MW, Amstadter AB, Baker DG, et al. The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large-Scale Genomic Collaboration. Neuropsychopharmacology. 2015;40(10):2287-97. doi:10.1038/npp.2015.118
Kim J, Akbani R, Creighton CJ, et al. Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise. Clin Cancer Res. 2015;21(20):4514-24. doi:10.1158/1078-0432.CCR-14-1215
Doench JG, Fusi N, Sullender M, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34(2):184-91. doi:10.1038/nbt.3437